SLC1A5 and neoplasm: EVs-mediated drug resistance has been reported for many therapies like chemotherapy, radiotherapy, immunotherapy, etc. Therefore, we also checked if REVs or EVs from SLC1A5-OE (SLC1A5-OE-EVs) (Figure S4E-F) cells induced drug resistance in different tumor cell types.